List of Neurontin drug patents

Neurontin is owned by Viatris.

Neurontin contains Gabapentin.

Neurontin has a total of 2 drug patents out of which 2 drug patents have expired.

Expired drug patents of Neurontin are:

  • US7256216
  • US7256216*PED

Neurontin was authorised for market use on 02 March, 2000.

Neurontin is available in solution;oral dosage forms.

The generics of Neurontin are possible to be released after 28 November, 2022.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7256216 VIATRIS Liquid pharmaceutical compositions
May, 2022

(8 months ago)



VIATRIS Liquid pharmaceutical compositions
Nov, 2022

(2 months ago)

Drugs and Companies using GABAPENTIN ingredient

Market Authorisation Date: 02 March, 2000

Treatment: NA


How can I launch a generic of NEURONTIN before it's patent expiration?
More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic